Assessment of facility performance during mass treatment of chronic hepatitis C in Egypt: Enablers and obstacles-Reference-Cited by-同舟云学术

Assessment of facility performance during mass treatment of chronic hepatitis C in Egypt: Enablers and obstacles

Published:2020-09 Issue:9 Volume:13 Page:1322-1329
ISSN:1876-0341
Container-title:Journal of Infection and Public Health
language:en
Short-container-title:Journal of Infection and Public Health

Author:

Shousha Hend Ibrahim^ORCID,Said Mohamed,ElAkel Wafaa,ElShafei Arwa,Esmat Gamal,Waked Emam,Elsayed Manal Hamdy,Doss Wahid,elrazky Maysa,Mehrez Mai,Hassany Mohamed,zeyada Dina,Anis Mahmoud,Alserafy Magdy

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Medicine

Reference31 articles.

1. The current and future disease burden of chronic hepatitis C virus infection in Egypt;Waked;Arab JG,2014

2. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study;Blach;Lancet Gastroenterol Hepatol,2017

3. Egypt health issues survey 2015;Ministry of Health and Population [Egypt],2015

4. The prevalence of HCV infection in Egypt 2015: implications for future policy on prevention and treatment;Kandeel;Liver Int,2017

5. National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care;El-Akel;J Viral Hepat,2017

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prediction of hepatic decompensation and hepatocellular carcinoma after direct-acting antiviral therapy in patients with hepatitis C-related liver cirrhosis: a cohort study;Egyptian Liver Journal;2023-03-01

2. The impact of polymorphism in PNPLA3 and TM6SF2 genes on the susceptibility and survival of hepatitis C-related hepatocellular carcinoma;Egyptian Liver Journal;2022-09-24

3. Phalcon Framework Realization of Distributed Data-Oriented Collaborative Governance System of Sports Venues in Hubei Colleges;2022 International Conference on Sustainable Computing and Data Communication Systems (ICSCDS);2022-04-07

4. Plasma cell-free DNA integrity index and hepatocellular carcinoma treated or not with direct-acting antivirals: A case-control study;Arab Journal of Gastroenterology;2022-02

5. Three regimens for re-treatment failure of Sofosbuvir-based therapy for chronic hepatitis-C genotype-4: a cohort study;Revista do Instituto de Medicina Tropical de São Paulo;2022